Treatment for severe acute respiratory illness associated with coronavirus
OwnerSean Downinginventor
Life of this patent
Estimating the term…
Abstract
A method is provided for identifying a patient having a respiratory illness and administering to the patient a combination of an anti-inflammatory agent and a leukotriene inhibitor. The method may include treating respiratory illness associated with a coronavirus, and may it may further include reducing or preventing an inflammatory response or cytokine storm for those patients without impairing their immune response against the underlying pathogen.
Claims12
A method comprising:
- identifying a patient having a respiratory illness and administering to said patient a combination of an anti-inflammatory agent and a leukotriene inhibitor.
A method comprising:
- identifying a patient at risk of developing SARS and administering to said patient a combination of colchicine, montelukast and an NSAID.
A pharmaceutical composition comprising a combination of an anti-inflammatory agent and a leukotriene inhibitor.
An oral pharmaceutical composition comprising a combination of an anti-inflammatory agent and a leukotriene inhibitor.
A pharmaceutical composition comprising a combination of colchicine and montelukast.
Dependencies are inferred from the claim text.